Quick Overview of Ventas

By Blake Campbell • Tuesday, July 08 15:19 • Permanent Link

Join us for a quick overview of Ventas, a Specialty Real Estate Investment Trust company whose shares moved -0.4% today. Here are some facts about the stock that should help you see the bigger picture:

Ventas has moved 20.6% over the last year, and the S&P 500 logged a change of 11.7%
VTR has an average analyst rating of buy and is -17.21% away from its mean target price of $75.84 per share
Its trailing earnings per share (EPS) is $0.33
Ventas has a trailing 12 month Price to Earnings (P/E) ratio of 190.3 while the S&P 500 average is 29.3
Its forward earnings per share (EPS) is $0.16 and its forward P/E ratio is 392.4
The company has a Price to Book (P/B) ratio of 2.47 in contrast to the S&P 500's average ratio of 4.74
Ventas is part of the Real Estate sector, which has an average P/E ratio of 27.31 and an average P/B of 1.94
The company has a free cash flow of $869.68 Million, which refers to the total sum of all its inflows and outflows of cash over the last quarter
Ventas, Inc. (NYSE: VTR) is a leading S&P 500 real estate investment trust enabling exceptional environments that benefit a large and growing aging population. With approximately 1,400 properties in North America and the United Kingdom, Ventas occupies an essential role in the longevity economy. The Company's growth is fueled by its approximately 850 senior housing communities, which provide valuable services to residents and enable them to thrive in supported environments. Ventas aims to deliver outsized performance by leveraging its operational expertise, data-driven insights from its Ventas OI platform, extensive relationships and strong financial position. The Ventas portfolio also includes outpatient medical buildings, research centers and healthcare facilities. Ventas's seasoned team of talented professionals shares a commitment to excellence, integrity and a common purpose of helping people live longer, healthier, happier lives.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.